Bioventus Inc. (BVS) stock
BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3033% below fair value
$10.66−0.20 (-1.84%)
Close on Nov 13, 2026Market cap $896.42MP/E 13.3Yield –
Bioventus operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Bioventus's operating cash flow for the twelve months ending Sep 26, 2026 was $87.43M, up 56.1% year over year. For fiscal 2025 it was $74.67M, up 92.5% from the year before. The highest annual figure on record is $74.67M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $74.67M | +92.5% |
| FY2024 | Dec 31, 2024 | $38.80M | +152.8% |
| FY2023 | Dec 31, 2023 | $15.34M | – |
| FY2022 | Dec 31, 2022 | -$13.54M | -158.9% |
| FY2021 | Dec 31, 2021 | $22.99M | -68.0% |
| FY2020 | Dec 31, 2020 | $71.80M | +76.4% |
| FY2019 | Dec 31, 2019 | $40.71M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $20.66M | -31.4% |
| Q2 FY2026 | Jun 27, 2026 | $19.87M | -23.4% |
| Q1 FY2026 | Mar 28, 2026 | $8.93M | – |
| Q4 FY2025 | Dec 31, 2025 | $37.97M | +96.5% |
| Q3 FY2025 | Sep 27, 2025 | $30.10M | +191.8% |
| Q2 FY2025 | Jun 28, 2025 | $25.94M | +71.1% |
| Q1 FY2025 | Mar 29, 2025 | -$19.33M | – |
| Q4 FY2024 | Dec 31, 2024 | $19.32M | +86.3% |
| Q3 FY2024 | Sep 28, 2024 | $10.32M | – |
| Q2 FY2024 | Jun 29, 2024 | $15.16M | +40.5% |
| Q1 FY2024 | Mar 30, 2024 | -$6.01M | -341.2% |
| Q4 FY2023 | Dec 31, 2023 | $10.37M | +97.8% |
| Q3 FY2023 | Sep 30, 2023 | -$8.32M | – |
| Q2 FY2023 | Jul 1, 2023 | $10.80M | +267.3% |
| Q1 FY2023 | Apr 1, 2023 | $2.49M | – |
| Q4 FY2022 | Dec 31, 2022 | $5.24M | -60.0% |
| Q3 FY2022 | Oct 1, 2022 | -$701.00K | -106.6% |
| Q2 FY2022 | Jul 2, 2022 | $2.94M | -83.0% |
| Q1 FY2022 | Apr 2, 2022 | -$21.02M | – |
| Q4 FY2021 | Dec 31, 2021 | $13.12M | -48.5% |
| Q3 FY2021 | Oct 2, 2021 | $10.59M | -49.2% |
| Q2 FY2021 | Jul 3, 2021 | $17.33M | +121.6% |
| Q1 FY2021 | Apr 3, 2021 | -$18.04M | -202.0% |
| Q4 FY2020 | Dec 31, 2020 | $25.45M | – |
| Q3 FY2020 | Sep 26, 2020 | $20.84M | – |
| Q2 FY2020 | Jun 27, 2020 | $7.82M | – |
| Q1 FY2020 | Mar 28, 2020 | $17.69M | – |
See a number that looks wrong?